Syracuse University at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Syracuse University brings 3 presentations to ObesityWeek 2026 in National Harbor. Its program centers on new drug candidates, including a long-acting GLP-1 and Y2 receptor dual agonist and DG-260, a gliotransmitter analog for obesity and type 2 diabetes. It also compares metabolic adaptations after high-intensity interval training and time-restricted eating in young adults.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Syracuse University Syracuse, NY | |
Private research university in Syracuse, New York. | Talk Sat Nov 14 10:45am–11:00am Poster Sat Nov 14 7:30pm–8:30pm A Long-Acting GLP-1/Y2-Receptor Dual Agonist for the Treatment of Obesity Neuroscience of appetite and eatingNutrition, diet and food Poster Sun Nov 15 2:30pm–3:30pm Distinct Metabolic Adaptations Following HIIT and TRE in Young Adults With Overweight and Obesity Interventional and clinical studies |
Find decision makers at Syracuse University
Tell us what you sell and we’ll find the people at Syracuse University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction